Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 83 of 110 Updated Nov 17, 2026

Pentapeptide-18

Leuphasyl

COSMETIC CLINICAL STUDIES · COSMETIC PEPTIDE; ENKEPHALIN MIMETIC

▓ 11 indexed citations across PubMed (6), EuropePMC (5).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

11 citations across 1 tier

Tap any tier to jump to that section of the bibliography.

Mechanism of action

Enkephalin mimetic; modulates SNAP-25 at muscle-neuron interface (topical)

Researched effects

Expression wrinkle reduction; synergistic with Argireline

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

Topical 2-10%

Known concerns

Minimal

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Pentapeptide-18 as an anti-aging candidate: Spectroscopic characterization and molecular interaction analysis.

    Computational biology and chemistry · 2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  2. Integrative In Silico and In Vitro Evaluation of Vialox and Leuphasyl Pentapeptides for Antiaging Applications.

    Chemistry & biodiversity · 2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  3. A framework for the safety evaluation of peptides in cosmetics.

    2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  4. In Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides.

    Cell biochemistry and biophysics · 2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  5. Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review.

    2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  6. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers.

    2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  7. Retinol and Oligopeptide-Loaded Lipid Nanocarriers as Effective Raw Material in Anti-Acne and Anti-Aging Therapies.

    Life (Basel, Switzerland) · 2024 — RESEARCH ARTICLES · AUTHORITY 34.4

  8. Solid Lipid Nanoparticles Incorporated with Retinol and Pentapeptide-18-Optimization, Characterization, and Cosmetic Application.

    International journal of molecular sciences · 2024 — RESEARCH ARTICLES · AUTHORITY 34.4

  9. Peptide-pro complex serum: Investigating effects on aged skin.

    2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  10. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy.

    2020 — RESEARCH ARTICLES · AUTHORITY 34.0

Full citation library

Year distribution

Research Articles

11
  1. 1.

    Akhan D, Bicak B, Akalin E, Gunduz SK · Computational biology and chemistry · 2026 · PMID 41722287

    Skin aging is predominantly associated with the progressive breakdown of the dermal extracellular matrix (ECM), leading to visible manifestations such as wrinkle development caused by repetitive facial muscle movements and a gradual reduction in collagen and elastin synthesis. This degeneration is intensified by external factors including ultraviolet exposure, tobacco use, and nutritional imbalance, which interfere with major intracellular signaling pathways-namely TGF-β, TNF-α, MAPK, PI3K/AKT,…

  2. 2.

    Park J, Jung H, Jang B, Song HK, et al. · Scientific reports · 2020 · PMID 31937863

    D-tyrosine is known to negatively regulate melanin synthesis by inhibiting tyrosinase activity. Here, we further reveal that peptides containing terminal D-tyrosine can reduce the melanin contents of human melanocytes. The addition of D-tyrosine to the terminus of the commercial anti-wrinkle peptide, pentapeptide-18 endowed the peptide with the ability to reduce the melanin content and tyrosinase activity in human MNT-1 melanoma cells and primary melanocytes. Consistently, terminal D-tyrosine-co…

  3. 3.

    Pawłowska M, Marzec M, Jankowiak W, Nowak I · Life (Basel, Switzerland) · 2024 · PMID 39459512

    The use of lipid nanocarriers as components of cosmetic formulations may provide an opportunity to fully exploit the beneficial properties of pentapeptide-18 and retinol while reducing the undesirable effects that occur during retinoid therapy. This study aimed to evaluate the effectiveness of semi-solid formulations enriched with retinol and oligopeptide-loaded lipid nanocarriers. Solid lipid nanoparticles were produced using a high-shear homogenization method. The work included physicochemical…

  4. 4.

    Akhan D, Bicak B, Kurtur OB, Budama-Kilinc Y, et al. · Chemistry & biodiversity · 2026 · PMID 42116636

    Skin aging arises from intrinsic and extrinsic factors that drive extracellular matrix degradation, particularly of collagen and elastin, leading to wrinkles, pigmentation, and loss of skin elasticity. This is the first integrative study to evaluate the antiaging potential of the cosmeceutical pentapeptides Vialox and Leuphasyl using a combined approach of molecular docking, molecular dynamics simulations, and in vitro cytotoxicity assays. Targeting matrix metalloproteinases (MMP-1, MMP-8, and M…

  5. 5.

    Pawłowska M, Marzec M, Jankowiak W, Nowak I · International journal of molecular sciences · 2024 · PMID 39337562

    Solid lipid nanoparticles (SLNs) incorporated with retinol and oligopeptide can have a full spectrum of effects on the skin as a compatible combination of ingredients with broad anti-aging properties. The research's main objective was to ensure the stability of lipid nanocarriers containing retinol and peptide due to the planned use of this dispersion as a cosmetic raw material. To confirm the effectiveness of method optimization (high shear homogenization, HSH) and proper selection of substrate…

  6. 6.

    Pintea A, Manea A, Pintea C, Vlad RA, Bîrsan M, Antonoaea P, Rédai EM, Ciurba A. · 2025 · PMID 39858482

    One class of cosmetic compounds that have raised interest of many experts is peptides. The search for ingredients with good biocompatibility and bioactivity has led to the use of peptides in cosmetic products. Peptides are novel active ingredients that improve collagen synthesis, enhance skin cell proliferation, or decrease inflammation. Based on their mechanism of action, they can be classified into signal peptides, carrier peptides, neurotransmitter inhibitor peptides, and enzyme inhibitor pep…

  7. 7.

    Badilli U, Inal O. · 2025 · PMID 40292641

    Today's consumer perception and expectations of personal care have gone beyond merely cleansing, moisturizing, and makeup products, focusing more on the reduction or elimination of signs of aging. Cosmeceuticals, developed to create a more youthful appearance, commonly contain substances with therapeutic and physiological effects. The development of cosmeceutical products containing peptides, biotic ingredients, and marine-based compounds has become a highly popular strategy to enhance anti-agin…

  8. 8.

    Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. · 2020 · PMID 33195061

    Among the many aspects that contribute to the wellness of each individual, healthy and younger-looking skin play a relevant role, as clearly shown by the important growth of the skin-care products market observed in recent years. In this scenario, the field of cosmeceuticals appears particularly promising, being based on cosmetic products containing active ingredients. Among these, several peptides were proposed for cosmeceutical applications, thanks to their specific interaction with biological…

  9. 9.

    Bjerke DL, Li J, Gao Y, Hu P, Lintner K, Hakozaki T. · 2026 · PMID 41953401

    As the cosmetic industry replaces traditional animal safety studies with next generation risk assessment approaches, the approach to safety substantiation for peptides used in cosmetic products must also evolve. While the need to provide assurances of safety for local and systemic toxicity endpoints remains the same, adoption of bioinformatic tools developed in the food, agricultural biotechnology, and drug development industries may add to the weight of evidence for the safety substantiation of…

  10. 10.

    Moy M, Diaz I, Lesniak E, Giancola G. · 2023 · PMID 35426243

    <h4>Background</h4>Effective anti-aging treatments are an unmet consumer need.<h4>Aim</h4>Ex vivoand clinical tests have evaluated the efficacy of a topical facial serum containing a proprietary blend of neuropeptides, proteins, amino acids, and marine extracts on aged skin.<h4>Methods</h4>In the ex vivo study the facial serum was compared to a commercially marketed face serum and to an untreated control on skin explants using microrelief, smoothness, and epidermal thickness endpoints. The 12 we…

  11. 11.

    Akhan D, Bicak B, Akman G, Kecel Gunduz S · Cell biochemistry and biophysics · 2026 · PMID 42412310

    Cancer, resulting from uncontrolled cell proliferation, is a leading cause of death worldwide and its incidence continues to rise. Challenges such as late diagnosis, aggressive tumor biology, and therapeutic resistance limit the effectiveness of current treatment strategies. Therefore, therapeutic peptides capable of penetrating cells and exhibiting high target specificity have emerged as an innovative approach in cancer therapy. Peptides derived from animal venoms have demonstrated antitumor ac…

Curated sources on file

4
  1. 1.
  2. 2.
  3. 3.
    Note: Primary literature for this commercial cosmetic peptide is limited; cited reviews summarize available preclinical and clinical evidence.
  4. 4.

Continue reading